| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/22/2009 | US20090023731 Soluble epoxide hydrolase inhibitors |
| 01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
| 01/22/2009 | US20090023729 Trisubstituted amine compound |
| 01/22/2009 | US20090023728 1,2,3,4-Tetrahydroisoquinoline Derivatives, Preparations Thereof and Uses Thereof |
| 01/22/2009 | US20090023727 Phthalazinone derivatives |
| 01/22/2009 | US20090023726 ovarian cancer; HDAC inhibitors for example N-hydroxy-2-(4-(heteroarylmethylaminomethyl)piperidino)-pyrimidine-5-amide |
| 01/22/2009 | US20090023725 Fused Heteroaryl Derivatives for Use as P38 Kinase Inhibitors |
| 01/22/2009 | US20090023723 Purinone derivatives for treating neurodegenerative diseases |
| 01/22/2009 | US20090023721 Novel Substituted Tetracyclic Tetrahydrofuran, Pyrrolidine and Tetrahydrothiophene Derivatives and Their Use as a Medicament |
| 01/22/2009 | US20090023720 2-Amino 1H-Imidazo Ring Systems and Methods |
| 01/22/2009 | US20090023719 4-(Benzo[d]dioxol-4-ylamino)- or 4-(indazol-4-ylamino)- substituted 2,4-pyrimidinediamine derivatives: N4-(5-chlorobenzo[d][1,3]dioxol-4-yl)-N2-(2,6-dimorpholinopyridin-4-yl)pyrimidine-2,4-diamine; N-(4,6-dimorpholin-4-ylpyrimidin-2-yl)-N'-(1H-indazol-4-yl)-N'-methyl-pyrimidine-2,4-diamine; anticancer |
| 01/22/2009 | US20090023709 Inhibitors of 11B-Hyrdoxysteroid Dehydrogenase |
| 01/22/2009 | US20090023707 1-{4-[4-(pyrrolidin-1-ylmethyl)-1,3-oxazol-2-yl]benzyl}-1H-benzimidazole, used for the treatment of central nervous system disorders |
| 01/22/2009 | US20090023173 Luminescence-based methods and probes for measuring cytochrome P450 activity |
| 01/22/2009 | US20090022688 Inhibitors of serine protease, particularly hcv ns3-ns4a protease |
| 01/22/2009 | CA2695004A1 Compounds and methods for kinase modulation, and indications therefor |
| 01/22/2009 | CA2693594A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
| 01/22/2009 | CA2693588A1 Sodium channel inhibitors |
| 01/22/2009 | CA2693406A1 Compounds and methods for modulating fxr |
| 01/22/2009 | CA2693138A1 Aminoalkylazole derivatives as histamine-3 antagonists |
| 01/22/2009 | CA2692713A1 Heterocyclic modulators of pkb |
| 01/22/2009 | CA2690761A1 Benzimidazole poly(adp-ribose)polymerase inhibitors |
| 01/21/2009 | EP2017275A1 Benzisoxazole compound |
| 01/21/2009 | EP2017263A1 Heteroarylamide lower carboxylic acid derivative |
| 01/21/2009 | EP2016078A2 Pyrrolo- and thiazolo-pyridine compounds as hif modulators |
| 01/21/2009 | EP2016074A1 Inhibitors of c-fms kinase |
| 01/21/2009 | EP2016072A1 Factor xa inhibitors |
| 01/21/2009 | EP2016067A1 Insecticidal compounds |
| 01/21/2009 | EP2016049A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors |
| 01/21/2009 | EP2016047A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| 01/21/2009 | EP1674460B1 Chromene compound |
| 01/21/2009 | EP1664026B1 Mitotic kinesin inhibitors |
| 01/21/2009 | EP1663983B1 N-substituted, 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators |
| 01/21/2009 | EP1562939B1 Carboxamides |
| 01/21/2009 | EP1531816B1 Spirocyclic piperidines as mch1 antagonists and uses thereof |
| 01/21/2009 | EP1444211B1 Quinazoline derivatives as antitumor agents |
| 01/21/2009 | EP0958291B1 3-heterocyclyl-substituted benzoyl derivatives |
| 01/21/2009 | CN101351462A 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1(VR1) activity |
| 01/21/2009 | CN101351461A Aryl-isoxazol-4-yl-imidazole derivatives |
| 01/21/2009 | CN101351456A Isoxazolines for controlling invertebrate pests |
| 01/21/2009 | CN101351446A Novel fused pyrrole derivatives |
| 01/21/2009 | CN101348467A Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 01/21/2009 | CN100453541C Substituted oxdiazole or triazole thioketone compounds, preparation and application thereof |
| 01/21/2009 | CN100453533C Acceptor excitant of a class of pancreas hyperglycemia peptide-1, preparation method and usage |
| 01/21/2009 | CN100453532C Substituted anthranilamides for controlling invertebrate pests |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479559 3-[-2-(Piperazin-1-yl)benzyl]pyrrolidin-2-one derivatives; antidepressants, anxiolytic agents; obsessive compulsive disorder, psychological disorders, phobias; 5-HT1 agonist or antagonists; side effect reduction, in particular cardiac QTc prolongation; hydrogenation |
| 01/20/2009 | US7479558 Chemical intermediates |
| 01/20/2009 | US7479557 Iron, osmium, platinum, rhenium, or ruthenium metal complexes of naphthalenediimide derivatives having imidazole and/or morpholine groups; nucleic acid detection; imidation, complexing, hybridizaton, immobilization; genetic engineering |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479501 Heteroaryl-cyclic acetals |
| 01/20/2009 | US7479500 Antidepressant piperidine derivatives of heterocyclefused benzodioxans |
| 01/20/2009 | US7479471 Applying to plants, seeds |
| 01/20/2009 | CA2502856C Intermediates for retroviral protease inhibiting compounds |
| 01/20/2009 | CA2477839C Nitrogen containing heterocyclic compounds and medicines containing the same |
| 01/20/2009 | CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 01/20/2009 | CA2372836C Substituted pyrrolidines as cell adhesion inhibitors |
| 01/20/2009 | CA2339961C Isoquinoline derivatives with angiogenesis inhibiting activity |
| 01/20/2009 | CA2337770C Amide derivatives which are useful as cytokine inhibitors |
| 01/20/2009 | CA2322204C 5-aminoindeno(1,2-c)pyrazol-4-ones as anti-cancer and anti-proliferative agents |
| 01/20/2009 | CA2293368C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 01/20/2009 | CA2220759C 1,4-benzodioxin derivatives |
| 01/15/2009 | WO2009009531A2 Pyrimidinecarboxamide derivatives for the treatment of hiv infections |
| 01/15/2009 | WO2009009003A1 Process for the production of substituted 5-quinolyl-oxazoles and pharmaceutically acceptable salts thereof |
| 01/15/2009 | WO2009007751A2 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 01/15/2009 | WO2009007749A2 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 01/15/2009 | WO2009007748A2 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 01/15/2009 | WO2009007747A2 Hydantoin derivatives used as mmp12 inhibitors |
| 01/15/2009 | WO2009007329A1 Crystalline form of [3-(4,5-dihydro-3-isoxazolyl)-2-methyl-4-(methylsulfonyl)phenyl]-(5-hydroxy-1-methyl-1h-pyrazol-4-yl)methanone |
| 01/15/2009 | WO2009007074A1 Pyrimidinyl pyridazinone derivates |
| 01/15/2009 | WO2009007027A1 Aminoacyl prodrugs as an active pharmaceutical ingredient for thromboembolic disorders |
| 01/15/2009 | WO2009007026A1 Aminoacyl prodrugs |
| 01/15/2009 | WO2009007015A1 Malonamide derivatives with antithrombotic activity |
| 01/15/2009 | WO2009006959A1 Pyridazinone derivates |
| 01/15/2009 | WO2008122375A3 Insecticidal aryl isoxazoline derivatives |
| 01/15/2009 | WO2008097546A3 Compounds that inhibit cholinesterase |
| 01/15/2009 | WO2008089005A3 Renin inhibitors |
| 01/15/2009 | US20090018160 Heterocyclic Compounds with Affinity to Muscarinic Receptors |
| 01/15/2009 | US20090018150 5-Ht2b Receptor Antagonists |
| 01/15/2009 | US20090018144 Capped pyrazinoylguanidine sodium channel blockers |
| 01/15/2009 | US20090018134 Compounds - 945 |
| 01/15/2009 | US20090018133 Novel Adamantane Derivatives |
| 01/15/2009 | US20090018132 Substituted Heterocyclic Ethers and Their Use in CNS Disorders |
| 01/15/2009 | US20090018131 Quinazoline derivatives as p13 kinase inhibitors |
| 01/15/2009 | US20090018126 pyrimidine- or pyridinecarboxylic acid derivatives which are substituted in the 2- or 4-position by an optionally substituted 4-(3-oxomorpholin-4-yl)aniline radical, such as 6-methyl-2-[4-(3-oxomorpholin-4-yl)phenylamino]nicotinic acid, suitable for the treatment of viral diseases, such as hepatitis C |
| 01/15/2009 | US20090018123 Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation |
| 01/15/2009 | US20090018122 Aryloxy and Arylalkyleneoxy Substituted Imidazoquinolines |
| 01/15/2009 | US20090018087 Neuronal disorders such as Alzheimer's disease, Down Syndrome, Parkinson disease, Chorea Huntington, pathogenic psychotic conditions, schizophrenia, impaired food intake, sleep-wakefulness, impaired homeostatic regulation of energy metabolism, impaired autonomic function; alcoholism |
| 01/15/2009 | US20090018056 Heteroarylcarbamoylbenzene derivatives |
| 01/15/2009 | US20090018054 Cholesteryl Ester Transfer Protein Inhibitors |
| 01/15/2009 | US20090015144 Fluoranthene compound, organic electroluminescence device using the same, and solution containing organic electroluminescence material |
| 01/15/2009 | DE102007032347A1 Aminoacyl-Prodrugs Aminoacyl prodrugs |
| 01/15/2009 | DE102007032345A1 Aminoacyl-Prodrugs Aminoacyl prodrugs |
| 01/15/2009 | CA2702317A1 Novel pyrimidinecarboxamide derivatives |
| 01/15/2009 | CA2693603A1 Aminoacyl prodrugs |
| 01/15/2009 | CA2693600A1 Pyridazinone derivatives |
| 01/15/2009 | CA2693507A1 Aminoacyl prodrugs as an active pharmaceutical ingredient for thromboembolic disorders |
| 01/15/2009 | CA2693396A1 Malonamide derivatives with antithrombotic activity |
| 01/15/2009 | CA2692945A1 Compounds - 945 |
| 01/15/2009 | CA2692867A1 Pyrimidinyl-pyridazinone derivatives |